[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-hitgen":3},{"head":4,"company":39,"invest":44,"children":45,"shops":46,"category":47,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":5,"likes":5,"unlikes":5,"follow":5,"pagetitle":20,"pagekeywords":21,"pagedesc":22,"brandContent":23,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":35,"enterWebsite":36,"business":37,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"140332","\u002Fprofile\u002Fupload\u002F2023\u002F12\u002F02\u002F7d0edd7692984862291b389c82276808.gif","成都先导HITGEN","hitgen",141367,9703,"028-85197385","2012年","成都市",469,0,"1","成都先导药物开发股份有限公司",[],"成都先导HITGEN简介-成都先导CRO医药外包-品牌之家","成都先导HITGEN品牌介绍,成都先导CRO医药外包好不好,成都先导怎么样,成都先导,成都先导药物开发股份有限公司","成都先导HITGEN品牌简介，品牌之家为你介绍成都先导药物开发股份有限公司旗下成都先导HITGEN品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你成都先导CRO医药外包怎么样，致力于帮助你了解成都先导HITGEN真实有效的品牌相关信息。","成都先导药物开发股份有限公司是一家从事新药研发的生物技术公司，总部位于中国成都，在英国剑桥、美国休斯顿设有子公司，并于2020年4月在上海证券交易所科创板挂牌上市（股票名称：成都先导，股票代码：688222.SH）。\n\n成都先导为小分子及核酸新药发现与优化建立了一个国际领先的，以DNA编码化合物库的设计、合成和筛选（DEL），以及基于分子片段和三维结构信息的药物设计（FBDD\u002FSBDD）为核心的技术平台。目前，公司基于数千种不同的骨架结构，已经完成超过万亿种结构新、具有多样性和类药性的DNA编码化合物的合成，并且已有多个案例证实了其针对已知生物靶点和新兴生物靶点筛选苗头化合物的能力及有效性。\n\n2020年底前，成都先导并购了坐落于英国剑桥的Vernalis公司，该公司是FBDD\u002FSBDD技术的领先者。现在，成都先导拥有超过500人的科学家团队，并且能够提供一整套从靶基因到新药临床试验申请阶段的研发服务，覆盖范围包括重组蛋白表达纯化、结构生物学、计算化学与药物化学、生物化学和生物物理学、细胞生物学、体内药理学、药代动力学、药学研究等。\n\n成都先导核酸药物研发平台包括生物信息学、核酸药物化学、RNA生物学、分子与细胞生物学、转化研究以及临床医学等。该核酸药物研发平台不仅能提供高质量的定制化的RNAi技术服务，还能提供高质量的siRNA设计、siRNA的平行合成与化学修饰，并进行基因敲除活性测试、稳定性测试、脱靶风险评估及核酸药物体内分布及其他体内外生物功能评价等。目前，公司已在恶性实体肿瘤和免疫性疾病领域建立了小核酸新药产品管线，旨在开发符合临床需求的小核酸新药。目前项目处于早期阶段。\n\n成都先导业务模式灵活，范围包括基于单一功能的服务（FFS，如蛋白表达与纯化、结构生物学、生物信息学、计算化学、药物化学、核酸及有机合成、分析化学、生物物理、细胞生物学、药代、药效等）、DEL 筛选、DEL设计、合成及表征、整合式药物发现项目、风险分担项目、合资企业到项目转让许可。成都先导建立了自主研发新药管线，拥有大约20个内部新药项目，分别处于临床及临床前不同阶段，目前已有4个项目获得临床试验批件并进入临床试验。成都先导业务遍布北美、欧洲、亚洲、非洲及澳大利亚等，现已与多家国际制药公司、生物技术公司、化学公司、基金会以及科研机构建立合作，致力于新药的发现与应用。","四川省成都高新区科园南路88号1栋3层","91510100590230753C","股份有限公司（外商投资、上市）","JIN LI","2012-02-22","成都高新区市场监督管理局","-","2020-06-17","40,068万(元)","36,000万(元)","药物研发并提供技术咨询、技术转让、技术服务。（依法须经批准的项目，经相关部门批准后方可开展经营活动）","85197385","www.dnaencodedlibrary.com","研究和试验发展","fm.deng@hitgen.com",{"enterId":40,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":35,"enterWebsite":36,"business":37,"performance":41,"socialSecurity":42,"registrationNumber":43,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"141367","开业","379人","510109000239125",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[48,67],{"createTime":49,"updateTime":50,"createBy":5,"updateBy":5,"industryId":51,"webId":5,"industryName":52,"industryAlias":53,"industryIcon":5,"industryTrans":54,"pageTitle":55,"pageDesc":56,"pageKeywords":57,"mainTitle":58,"pageSubtitle":59,"indSummary":60,"industryLevel":61,"parentId":62,"parentName":63,"sortOrder":64,"status":16,"classifyVisit":65,"totalVisits":66,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-14 16:50:00","5593","药品","药品,药物,医药制剂,医疗药品,医用药品,药片","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F175454c1767ce2414a13f8c3c16194de.png","十大药品品牌-药品十大厂家-ZGALL品牌榜","2026年药品行业十大品牌权威发布！药品排行榜前十名品牌有三九、同仁堂、广药白云山、云南白药、太极药业、修正、念慈菴、天士力、扬子江药业、仁和。药品10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解药品哪个牌子好。","药品十大品牌排名,OTC药品十大品牌,非处方药品牌十大排行榜,OTC药品排行,药品品牌有哪些","药品品牌排行榜","2026药品品牌排行榜，OTC药品排行，OTC常用药品有哪些","药品什么牌子好？品牌TOP榜权威发布2026年药品十大品牌名录；居前十的有：三九999、同仁堂、广药白云山、云南白药、太极药业TAIJI、修正、京都念慈菴、天士力TASLY、扬子江药业、仁和药业RenHe等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,"医药用品",20,12,1057,{"createTime":49,"updateTime":68,"createBy":5,"updateBy":5,"industryId":69,"webId":5,"industryName":70,"industryAlias":5,"industryIcon":5,"industryTrans":71,"pageTitle":72,"pageDesc":73,"pageKeywords":74,"mainTitle":75,"pageSubtitle":76,"indSummary":77,"industryLevel":61,"parentId":62,"parentName":5,"sortOrder":78,"status":16,"classifyVisit":5,"totalVisits":79,"searchName":5,"starLevel":5,"limit":5},"2026-06-16 16:50:00","9703","CRO医药外包","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F0262445f374db14832736266b03a6887.png","CRO医药外包公司十大排行榜-医药外包研发公司有哪些-ZGALL品牌榜","2026年十大CRO医药外包公司最新发布，CRO医药外包公司排行榜前十名品牌有药明康德、康龙化成、徕博科、IQVIA、赛默飞世尔、泰格、凯莱英、昭衍、睿智医药、九洲。CRO医药外包公司十大排行榜由品牌研究部门收集整理大数据分析研究得出，帮助你了解CRO企业有哪些。","医药研发cro公司排名,医药外包研发公司排名前十名,国内cro企业排名,国内CRO企业有哪些,医药外包研发企业排名榜","CRO医药外包品牌排行榜","2026CRO医药外包公司排行榜，合同研究组织-医药外包研发公司榜中榜，CRO企业有哪些","CRO医药外包什么牌子好？品牌TOP榜权威发布2026年CRO医药外包十大品牌名录；居前十的有：药明康德、康龙化成PHARMARON、labcorp徕博科、IQVIA、ThermoFisher赛默飞世尔、泰格医药Tigermed、凯莱英CASYMCHEM、昭衍JOINN、睿智医药、九洲药业JIUZHOU等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",99,46085]